Parameters affecting the drug release from in situ gelling nasal inserts

The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, dip...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmaceutics and biopharmaceutics Vol. 63; no. 3; pp. 310 - 319
Main Authors Bertram, Ulrike, Bodmeier, Roland
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.07.2006
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, diprophyllin, and acetaminophen (APAP) were prepared by lyophilization. Drug release studies at different drug loadings were performed in various release media. Raman analysis, DSC, and SEM were conducted to analyze the physical state of the drugs in the inserts. All drugs were dissolved in the solid HPMC inserts and were released at similar rates at all investigated loadings except for the least soluble APAP. APAP concentrations in the hydrating HPMC K15M inserts in excess of its solubility limit resulted in reduced relative release rates at higher drug loadings. Drug–polymer interactions (formation of less soluble drug–polymer salts) resulted in a slower release of oxymetazoline HCl from carrageenan inserts than from HPMC K15M inserts. Changes in the composition of the release medium affected the water uptake of carrageenan but not of HPMC K15M inserts. Oxymetazoline release from carrageenan inserts increased with higher Na +-content of the medium because of ion exchange and at low (pH 2) as well as at high pH (pH 10). The osmolality of the release medium had no effect. The solubility of the drug, its physical state in the polymer matrix, and drug–polymer interactions governed the drug release from nasal inserts. The release from inserts prepared with oppositely charged polymers and drugs was influenced by electrostatic drug–polymer interactions and by the composition of the release medium.
AbstractList The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, diprophyllin, and acetaminophen (APAP) were prepared by lyophilization. Drug release studies at different drug loadings were performed in various release media. Raman analysis, DSC, and SEM were conducted to analyze the physical state of the drugs in the inserts. All drugs were dissolved in the solid HPMC inserts and were released at similar rates at all investigated loadings except for the least soluble APAP. APAP concentrations in the hydrating HPMC K15M inserts in excess of its solubility limit resulted in reduced relative release rates at higher drug loadings. Drug-polymer interactions (formation of less soluble drug-polymer salts) resulted in a slower release of oxymetazoline HCl from carrageenan inserts than from HPMC K15M inserts. Changes in the composition of the release medium affected the water uptake of carrageenan but not of HPMC K15M inserts. Oxymetazoline release from carrageenan inserts increased with higher Na+-content of the medium because of ion exchange and at low (pH 2) as well as at high pH (pH 10). The osmolality of the release medium had no effect. The solubility of the drug, its physical state in the polymer matrix, and drug-polymer interactions governed the drug release from nasal inserts. The release from inserts prepared with oppositely charged polymers and drugs was influenced by electrostatic drug-polymer interactions and by the composition of the release medium.
The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, diprophyllin, and acetaminophen (APAP) were prepared by lyophilization. Drug release studies at different drug loadings were performed in various release media. Raman analysis, DSC, and SEM were conducted to analyze the physical state of the drugs in the inserts. All drugs were dissolved in the solid HPMC inserts and were released at similar rates at all investigated loadings except for the least soluble APAP. APAP concentrations in the hydrating HPMC K15M inserts in excess of its solubility limit resulted in reduced relative release rates at higher drug loadings. Drug–polymer interactions (formation of less soluble drug–polymer salts) resulted in a slower release of oxymetazoline HCl from carrageenan inserts than from HPMC K15M inserts. Changes in the composition of the release medium affected the water uptake of carrageenan but not of HPMC K15M inserts. Oxymetazoline release from carrageenan inserts increased with higher Na +-content of the medium because of ion exchange and at low (pH 2) as well as at high pH (pH 10). The osmolality of the release medium had no effect. The solubility of the drug, its physical state in the polymer matrix, and drug–polymer interactions governed the drug release from nasal inserts. The release from inserts prepared with oppositely charged polymers and drugs was influenced by electrostatic drug–polymer interactions and by the composition of the release medium.
Author Bertram, Ulrike
Bodmeier, Roland
Author_xml – sequence: 1
  givenname: Ulrike
  surname: Bertram
  fullname: Bertram, Ulrike
– sequence: 2
  givenname: Roland
  surname: Bodmeier
  fullname: Bodmeier, Roland
  email: bodmeier@zedat.fu-berlin.de
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17878183$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16513333$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1r3DAQhkXY0uwm_QM9FF_amx2NZa9k6KWEthsIpIfkLGRptNHij63GDvTfR2YX9ta5DAzP-zI8G7YaxgEZ-wy8AA7bu0OBh2NblJzXBUDBubpia1BS5KKqYMXWvBFNvq0ArtmG6MA5r2StPrJr2NYg0qzZ7o-JpscJI2XGe7RTGPbZ9IqZi_M-i9ihIcx8HPssDBmFac722HULNRgyXboSxolu2QdvOsJP533DXn79fL7f5Y9Pvx_ufzzmVqhqym1lOShA05Q1lLIRWJWNaJ011oNDJ4WVdemddKK0TQteVCXUVjjbeuk8iBv27dR7jOPfGWnSfSCbPjIDjjPpreIgleIJLE-gjSNRRK-PMfQm_tPA9eJPH_TiTy_-NIBO_lLoy7l9bnt0l8hZWAK-ngFD1nQ-msEGunBSSQVq4b6fOEwu3gJGTTbgYNGFmCRrN4b__fEO9cSQZA
CitedBy_id crossref_primary_10_1208_s12249_013_9956_y
crossref_primary_10_1155_2013_958465
crossref_primary_10_1016_j_ijpharm_2008_02_025
crossref_primary_10_2166_wst_2016_362
crossref_primary_10_1007_s12034_014_0697_7
crossref_primary_10_1208_s12249_014_0171_2
crossref_primary_10_1039_C5RA27785J
crossref_primary_10_1016_j_jddst_2015_11_004
crossref_primary_10_1016_j_carbpol_2016_07_075
crossref_primary_10_3109_03639045_2011_598536
crossref_primary_10_1080_03602559_2016_1253734
crossref_primary_10_1155_2013_139864
crossref_primary_10_1002_polb_21549
crossref_primary_10_1002_smtd_202301726
crossref_primary_10_53879_id_60_10_12854
crossref_primary_10_1016_j_msec_2016_03_091
crossref_primary_10_1016_j_chroma_2009_10_050
crossref_primary_10_1080_00914037_2013_830257
Cites_doi 10.1164/ajrccm.160.2.9805117
10.1016/S0169-409X(97)00063-X
10.1016/S0168-3659(01)00389-3
10.1016/S0939-6411(01)00135-7
10.1177/000348949810700109
10.1295/polymj.14.181
10.1016/S1773-2247(04)50048-5
10.1016/S0378-5173(01)00930-9
10.1023/A:1013330815253
10.1172/JCI119802
10.1016/S0264-410X(01)00188-8
10.1016/S0378-5173(99)00442-1
10.1164/ajrccm/137.3.625
10.1016/0378-5173(95)00070-Y
ContentType Journal Article
Copyright 2005 Elsevier B.V.
2006 INIST-CNRS
Copyright_xml – notice: 2005 Elsevier B.V.
– notice: 2006 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ejpb.2005.11.008
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3441
EndPage 319
ExternalDocumentID 10_1016_j_ejpb_2005_11_008
16513333
17878183
S0939641105003139
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SES
SEW
SPCBC
SSP
SSU
SSZ
T5K
TEORI
UNMZH
~G-
ABPIF
ABPTK
IQODW
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c384t-c4c0181ea92512793e4293bdcacf1ded73c752fd7d32c9b1f34215c3dcbf7df13
IEDL.DBID .~1
ISSN 0939-6411
IngestDate Fri Oct 25 02:31:38 EDT 2024
Thu Sep 26 17:27:41 EDT 2024
Sat Sep 28 07:41:26 EDT 2024
Sun Oct 22 16:10:05 EDT 2023
Fri Feb 23 02:28:03 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Nasal drug delivery
Release medium
Drug–polymer interaction
Inserts
Carrageenan
Extended drug release
HPMC
Drug
Pharmaceutical technology
Controlled release form
In situ
Polymer
Intranasal administration
Insert
Dosage form
Drug interaction
Drug-polymer interaction
Release
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c384t-c4c0181ea92512793e4293bdcacf1ded73c752fd7d32c9b1f34215c3dcbf7df13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16513333
PQID 68017880
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_68017880
crossref_primary_10_1016_j_ejpb_2005_11_008
pubmed_primary_16513333
pascalfrancis_primary_17878183
elsevier_sciencedirect_doi_10_1016_j_ejpb_2005_11_008
PublicationCentury 2000
PublicationDate 2006-07-01
PublicationDateYYYYMMDD 2006-07-01
PublicationDate_xml – month: 07
  year: 2006
  text: 2006-07-01
  day: 01
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle European journal of pharmaceutics and biopharmaceutics
PublicationTitleAlternate Eur J Pharm Biopharm
PublicationYear 2006
Publisher Elsevier B.V
Elsevier Science
Publisher_xml – name: Elsevier B.V
– name: Elsevier Science
References Sachdeva, Sachdeva, Gulati, Kakkar (bib12) 1993; 98
Behl, Pimplaskar, Sileno, deMeireles, Romeo (bib17) 1998; 29
Merkus, Verhoef (bib4) 1994; vol. 10
Junginger, Verhoef, Merkus (bib9) 1991; 131
Washington, Steele, Jackson, Bush, Mason, Gill, Pitt, Rawlins (bib10) 2000; 198
Teshima, Yamauchi, Makino, Kataoka, Arita, Nawata, Oishi (bib8) 2002; 233
Puttipipatkhachorn, Nunthanid, Ymamoto, Peck (bib18) 2001; 75
Togias, Proud, Lichtenstein, Adams, Norman, Kagey-Sobotka, Naclerio (bib13) 1988; 137
Hercules Inc., GENU
Majima, Harada, Shimizu, Takeuchi, Sakakura, Yoshinaga (bib16) 1999; 160
McInnes, Thapa, Stevens, Baillie, Watson, Nolan, Gibson (bib3) 2000
Oh, Kim, Hwang, Ko, Kim, Yang, Kim (bib6) 2001; 19
Akahane, Kawashima, Hirao, Shimizu, Minakata (bib19) 1982; 14
Pereswetoff-Morath, Edman (bib7) 1995; 124
J. Berendes, R. Link, F. Zöllner, Hals-Nasen-Ohren-Heilkunde in Praxis und Klinik: Obere und untere Luftwege, I. Thieme-Verlag, Stuttgart, Chapters 2, 10, 11, 16 (1977).
Atsuta, Majima (bib15) 1998; 107
Gupta, Hariharan, Wheatley, Price (bib20) 2001; 51
Knowles, Robinson, Wood, Pue, Mentz, Wager, Gatzy, Boucher (bib14) 1997; 100
R. Bodmeier, P. Maincent, Zubereitungen mit verlängerter Verweildauer am Applikationsort, German Patent DE 197 56 314 A 1, 1999.
carrageenan – general description. Product information, 1997.
Werner, Damgé, Maincent, Bodmeier (bib2) 2004; 14
Ahsan, Arnold, Meezan, Pillion (bib5) 2001; 18
10.1016/j.ejpb.2005.11.008_bib11
10.1016/j.ejpb.2005.11.008_bib21
Akahane (10.1016/j.ejpb.2005.11.008_bib19) 1982; 14
Atsuta (10.1016/j.ejpb.2005.11.008_bib15) 1998; 107
Werner (10.1016/j.ejpb.2005.11.008_bib2) 2004; 14
Oh (10.1016/j.ejpb.2005.11.008_bib6) 2001; 19
Majima (10.1016/j.ejpb.2005.11.008_bib16) 1999; 160
Ahsan (10.1016/j.ejpb.2005.11.008_bib5) 2001; 18
Pereswetoff-Morath (10.1016/j.ejpb.2005.11.008_bib7) 1995; 124
Teshima (10.1016/j.ejpb.2005.11.008_bib8) 2002; 233
10.1016/j.ejpb.2005.11.008_bib1
Washington (10.1016/j.ejpb.2005.11.008_bib10) 2000; 198
Togias (10.1016/j.ejpb.2005.11.008_bib13) 1988; 137
McInnes (10.1016/j.ejpb.2005.11.008_bib3) 2000
Junginger (10.1016/j.ejpb.2005.11.008_bib9) 1991; 131
Sachdeva (10.1016/j.ejpb.2005.11.008_bib12) 1993; 98
Puttipipatkhachorn (10.1016/j.ejpb.2005.11.008_bib18) 2001; 75
Behl (10.1016/j.ejpb.2005.11.008_bib17) 1998; 29
Merkus (10.1016/j.ejpb.2005.11.008_bib4) 1994; vol. 10
Knowles (10.1016/j.ejpb.2005.11.008_bib14) 1997; 100
Gupta (10.1016/j.ejpb.2005.11.008_bib20) 2001; 51
References_xml – volume: 100
  start-page: 2588
  year: 1997
  end-page: 2596
  ident: bib14
  article-title: Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects
  publication-title: J. Clin. Invest.
  contributor:
    fullname: Boucher
– volume: 131
  start-page: 295
  year: 1991
  end-page: 303
  ident: bib9
  article-title: Nasal Arzneiformen für die systemische Wirkstoffabsorption
  publication-title: Dtsch. Apoth. Ztg.
  contributor:
    fullname: Merkus
– volume: 14
  start-page: 181
  year: 1982
  end-page: 188
  ident: bib19
  article-title: Ion selectivities of some extracellular viscous polysaccharides from red algae
  publication-title: Polymer J. (Tokyo, Japan)
  contributor:
    fullname: Minakata
– volume: 198
  start-page: 139
  year: 2000
  end-page: 146
  ident: bib10
  article-title: Determination of baseline human nasal pH and the effect of intranasally administered buffers
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Rawlins
– volume: 19
  start-page: 4519
  year: 2001
  end-page: 4525
  ident: bib6
  article-title: Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery
  publication-title: Vaccine
  contributor:
    fullname: Kim
– volume: 107
  start-page: 47
  year: 1998
  end-page: 51
  ident: bib15
  article-title: Nasal mucociliary clearance of chronic sinusitis in relation to rheological properties of nasal mucus
  publication-title: Ann. Otol. Rhinol. Laryngol.
  contributor:
    fullname: Majima
– volume: 137
  start-page: 625
  year: 1988
  end-page: 629
  ident: bib13
  article-title: The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air
  publication-title: Am. Rev. Respir. Dis.
  contributor:
    fullname: Naclerio
– volume: 14
  start-page: 275
  year: 2004
  end-page: 284
  ident: bib2
  article-title: Properties of in situ gelling nasal insert containing estradiol/methyl β-cyclodextrin
  publication-title: J. Drug Del. Sci. Technol.
  contributor:
    fullname: Bodmeier
– volume: vol. 10
  start-page: 191
  year: 1994
  end-page: 220
  ident: bib4
  article-title: Nasal drug delivery: trends and perspectives
  publication-title: Encyclopedia of Pharmaceutical Technology
  contributor:
    fullname: Verhoef
– volume: 98
  start-page: 265
  year: 1993
  end-page: 268
  ident: bib12
  article-title: Nasal mucociliary clearance and mucus pH in patients with diabetes mellitus
  publication-title: Indian J. Med. Res.
  contributor:
    fullname: Kakkar
– volume: 51
  start-page: 241
  year: 2001
  end-page: 248
  ident: bib20
  article-title: Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Price
– volume: 75
  start-page: 143
  year: 2001
  end-page: 153
  ident: bib18
  article-title: Drug physical state and drug–polymer interaction on drug release from chitosan matrix films
  publication-title: J. Contr. Rel.
  contributor:
    fullname: Peck
– volume: 18
  start-page: 1742
  year: 2001
  end-page: 1746
  ident: bib5
  article-title: Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats
  publication-title: Pharm. Res.
  contributor:
    fullname: Pillion
– volume: 233
  start-page: 61
  year: 2002
  end-page: 66
  ident: bib8
  article-title: Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Oishi
– volume: 124
  start-page: 37
  year: 1995
  end-page: 44
  ident: bib7
  article-title: Dextran microspheres as a potential nasal drug delivery system for insulin – in vitro and in vivo properties
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Edman
– start-page: 2121
  year: 2000
  ident: bib3
  article-title: Nasal absorption of nicotine in sheep from a lyophilised insert formulation
  publication-title: AAPS Ann. Meeting
  contributor:
    fullname: Gibson
– volume: 160
  start-page: 421
  year: 1999
  end-page: 426
  ident: bib16
  article-title: Effect of biochemical components on rheologic properties of nasal mucus in chronic sinusitis
  publication-title: Am. J. Respir. Crit. Care Med.
  contributor:
    fullname: Yoshinaga
– volume: 29
  start-page: 89
  year: 1998
  end-page: 116
  ident: bib17
  article-title: Effects of physicochemical properties and other factors on systemic nasal drug delivery
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Romeo
– volume: 160
  start-page: 421
  year: 1999
  ident: 10.1016/j.ejpb.2005.11.008_bib16
  article-title: Effect of biochemical components on rheologic properties of nasal mucus in chronic sinusitis
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.160.2.9805117
  contributor:
    fullname: Majima
– volume: 29
  start-page: 89
  year: 1998
  ident: 10.1016/j.ejpb.2005.11.008_bib17
  article-title: Effects of physicochemical properties and other factors on systemic nasal drug delivery
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/S0169-409X(97)00063-X
  contributor:
    fullname: Behl
– volume: 75
  start-page: 143
  year: 2001
  ident: 10.1016/j.ejpb.2005.11.008_bib18
  article-title: Drug physical state and drug–polymer interaction on drug release from chitosan matrix films
  publication-title: J. Contr. Rel.
  doi: 10.1016/S0168-3659(01)00389-3
  contributor:
    fullname: Puttipipatkhachorn
– volume: 51
  start-page: 241
  issue: 3
  year: 2001
  ident: 10.1016/j.ejpb.2005.11.008_bib20
  article-title: Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/S0939-6411(01)00135-7
  contributor:
    fullname: Gupta
– ident: 10.1016/j.ejpb.2005.11.008_bib21
– volume: 107
  start-page: 47
  issue: 1
  year: 1998
  ident: 10.1016/j.ejpb.2005.11.008_bib15
  article-title: Nasal mucociliary clearance of chronic sinusitis in relation to rheological properties of nasal mucus
  publication-title: Ann. Otol. Rhinol. Laryngol.
  doi: 10.1177/000348949810700109
  contributor:
    fullname: Atsuta
– start-page: 2121
  issue: Suppl. 2
  year: 2000
  ident: 10.1016/j.ejpb.2005.11.008_bib3
  article-title: Nasal absorption of nicotine in sheep from a lyophilised insert formulation
  publication-title: AAPS Ann. Meeting
  contributor:
    fullname: McInnes
– volume: 14
  start-page: 181
  issue: 3
  year: 1982
  ident: 10.1016/j.ejpb.2005.11.008_bib19
  article-title: Ion selectivities of some extracellular viscous polysaccharides from red algae
  publication-title: Polymer J. (Tokyo, Japan)
  doi: 10.1295/polymj.14.181
  contributor:
    fullname: Akahane
– volume: 14
  start-page: 275
  issue: 4
  year: 2004
  ident: 10.1016/j.ejpb.2005.11.008_bib2
  article-title: Properties of in situ gelling nasal insert containing estradiol/methyl β-cyclodextrin
  publication-title: J. Drug Del. Sci. Technol.
  doi: 10.1016/S1773-2247(04)50048-5
  contributor:
    fullname: Werner
– volume: 233
  start-page: 61
  year: 2002
  ident: 10.1016/j.ejpb.2005.11.008_bib8
  article-title: Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(01)00930-9
  contributor:
    fullname: Teshima
– volume: 18
  start-page: 1742
  issue: 12
  year: 2001
  ident: 10.1016/j.ejpb.2005.11.008_bib5
  article-title: Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats
  publication-title: Pharm. Res.
  doi: 10.1023/A:1013330815253
  contributor:
    fullname: Ahsan
– volume: 100
  start-page: 2588
  issue: 10
  year: 1997
  ident: 10.1016/j.ejpb.2005.11.008_bib14
  article-title: Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI119802
  contributor:
    fullname: Knowles
– volume: 19
  start-page: 4519
  year: 2001
  ident: 10.1016/j.ejpb.2005.11.008_bib6
  article-title: Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(01)00188-8
  contributor:
    fullname: Oh
– volume: vol. 10
  start-page: 191
  year: 1994
  ident: 10.1016/j.ejpb.2005.11.008_bib4
  article-title: Nasal drug delivery: trends and perspectives
  contributor:
    fullname: Merkus
– volume: 198
  start-page: 139
  year: 2000
  ident: 10.1016/j.ejpb.2005.11.008_bib10
  article-title: Determination of baseline human nasal pH and the effect of intranasally administered buffers
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(99)00442-1
  contributor:
    fullname: Washington
– volume: 131
  start-page: 295
  issue: 8
  year: 1991
  ident: 10.1016/j.ejpb.2005.11.008_bib9
  article-title: Nasal Arzneiformen für die systemische Wirkstoffabsorption
  publication-title: Dtsch. Apoth. Ztg.
  contributor:
    fullname: Junginger
– ident: 10.1016/j.ejpb.2005.11.008_bib11
– volume: 137
  start-page: 625
  issue: 3
  year: 1988
  ident: 10.1016/j.ejpb.2005.11.008_bib13
  article-title: The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air
  publication-title: Am. Rev. Respir. Dis.
  doi: 10.1164/ajrccm/137.3.625
  contributor:
    fullname: Togias
– volume: 124
  start-page: 37
  year: 1995
  ident: 10.1016/j.ejpb.2005.11.008_bib7
  article-title: Dextran microspheres as a potential nasal drug delivery system for insulin – in vitro and in vivo properties
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)00070-Y
  contributor:
    fullname: Pereswetoff-Morath
– ident: 10.1016/j.ejpb.2005.11.008_bib1
– volume: 98
  start-page: 265
  issue: 3
  year: 1993
  ident: 10.1016/j.ejpb.2005.11.008_bib12
  article-title: Nasal mucociliary clearance and mucus pH in patients with diabetes mellitus
  publication-title: Indian J. Med. Res.
  contributor:
    fullname: Sachdeva
SSID ssj0004758
Score 1.9836173
Snippet The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 310
SubjectTerms Administration, Intranasal
Biological and medical sciences
Carrageenan
Carrageenan - administration & dosage
Delayed-Action Preparations - chemistry
Drug–polymer interaction
Extended drug release
Gels - chemistry
General pharmacology
HPMC
Hydrogen-Ion Concentration
Hypromellose Derivatives
Inserts
Medical sciences
Methylcellulose - administration & dosage
Methylcellulose - analogs & derivatives
Nasal drug delivery
Nasal Mucosa - metabolism
Osmolar Concentration
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Release medium
Solubility
Static Electricity
Title Parameters affecting the drug release from in situ gelling nasal inserts
URI https://dx.doi.org/10.1016/j.ejpb.2005.11.008
https://www.ncbi.nlm.nih.gov/pubmed/16513333
https://search.proquest.com/docview/68017880
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EL4KIb9fHmoN40bq2SV_HRVxWRVlQwVvJq1IPdbG7By_-dmealiKoB68hIWEmmW-SzHwDcIwgnCLQWM_YhFJyYuMlaWC9JL8ItUxVGEnKd767j8ZP4uY5fF6AyzYXhsIqG9vvbHptrZuWQSPNwbQoBg94F08jgfAV1gSElMQnEP5wT59_dmEeIq5rdFJnj3o3iTMuxsu-TpV7VyEmTyox-TM4rUxlhSLLXa2L353RGpRGa7DaeJNs6Ba8Dgu23ICTiaOj_jhjj112VXXGTtikI6r-2ITxRFJoFvFrMlnHdSCOMfQImXmfvzAqp4IYxygDhRUlq4rZnL3YmsSblbLCiYuSPvOrLXgaXT1ejr2msoKneSJmnhaaiLqsTMm9wSNqEZa4Mlrq3DfWxFzHYZCb2PBAp8rPuUDXQHOjVR6b3OfbsFi-lXYXmFR5KmJtVGqtCAMlhQyMz6WI8OKYRH4PTluRZlNHoJG1kWWvGSmAKmGGeBPJUAE9CFupZ9-2QYYW_s9x_W8q6qZCg4Q-Ce_BUauzDA8Q_YrI0r7NqyxCjI7RivVgx6myGxtR8RvO9_65qH1Ydg82FNx7AIuz97k9RBdmpvr1Hu3D0vD6dnz_BSy48J4
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7R7aGVUNUXZUsBHyouJWwTOw8fEWK1bQGt1EXiZvmVVTiEFdk9cOlv70ycKEJqOXCNHNny2PN9tme-AfiKICwRaHzkfEEpObmLCpn4qCi_p1ZLk2aa8p0vr7LZtfh5k95swVmfC0NhlZ3vDz699dbdl0k3m5NVVU1-41lcZgLhK20FCOULeCmIH-OiPvkzxHmIvC3SSa0jat5lzoQgL3-7MuFihaQ8qcbkv9Fpe6UbnLMyFLv4PxttUWn6Ft50dJKdhhG_gy1fv4ejedCjfjhmiyG9qjlmR2w-KFU_fIDZXFNsFglsMt0GdiCQMaSEzN1vlozqqSDIMUpBYVXNmmq9YUvfqnizWjfYcVXTa37zEa6n54uzWdSVVogsL8Q6ssKSUpfXkvgN7lGPuMSNs9qWsfMu5zZPk9LljidWmrjkArmB5c6aMndlzHdgVN_VfheYNqUUuXVGei_SxGihExdzLTI8ORZZPIZv_ZSqVVDQUH1o2a0iA1ApzBSPIgoNMIa0n3X1aB0odPFP_nfwyERDV-iRkJTwMRz2NlO4g-hZRNf-btOoDEE6Rzc2hk_BlMO_GVW_4fzzMwd1CK9mi8sLdfHj6tcevA63NxTp-wVG6_uN30c-szYH7Xr9C85Q8jc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Parameters+affecting+the+drug+release+from+in+situ+gelling+nasal+inserts&rft.jtitle=European+journal+of+pharmaceutics+and+biopharmaceutics&rft.au=Bertram%2C+Ulrike&rft.au=Bodmeier%2C+Roland&rft.date=2006-07-01&rft.issn=0939-6411&rft.volume=63&rft.issue=3&rft.spage=310&rft_id=info:doi/10.1016%2Fj.ejpb.2005.11.008&rft_id=info%3Apmid%2F16513333&rft.externalDocID=16513333
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-6411&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-6411&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-6411&client=summon